Back to search

Ireland· IE-PA-EU/1/12/792/001

Dacogen 50 mg powder for concentrate for solution for infusion

A decitabine product containing decitabine, registered in Ireland by Janssen-Cilag International NV. The same ATC class is registered in 14 of our 19 countries.

ATC L01BC08

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedDacogen 50 mg powder for concentrate …ATCL01BC08REGISTER NO.IE-PA-EU/1/12/792/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Decitabine is registered in 14 of 19 countries.

Countries holding a registration under ATC L01BC08 (decitabine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Decitabine · ATC L01BC08

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of decitabine costs, country by country.

Normalised to the WHO defined daily dose (6.43 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Decitabine · price per daily dose (6.43 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$137.43
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Decitabine
Manufacturer
Janssen-Cilag International NV
Country
Ireland (IE)
ATC code
L01BC08
ATC class
Decitabine
Defined daily dose
6.43 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/12/792/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

112 interactions on record for decitabine.

Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Decitabine · interactions on record

112 records

  • 30 severe
  • 82 moderate

Most severe, free to view

  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Talimogen laherparepvecL01XX51severe
  • LeflunomidL04AA13severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Decitabine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All decitabine products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Decitabin Accord, Decitabine Ever Pharma
  • Belgium · Decitabine Ever Pharma, Decitabine Hikma
  • Bulgaria · Децитабин Ever Pharma
  • Cyprus · Decitabine Accord, Decitabine Teva
  • Denmark · Decitabin Teva, Decitabine "sandoz"
  • Spain · Decitabina Accord, Decitabina Eugia
  • Finland · Decitabine Ever Pharma
  • United Kingdom (Northern Ireland) · Decitabine Hikma Farmacêutica (Portugal)
  • Croatia · Decitabin Accord, Decitabine Ever Pharma
  • Hungary · Decitabine Ever Pharma
  • Iceland · Dacogen
  • Italy · Decitabina Accord, Decitabina Aurobindo
  • Liechtenstein · Dacogen
  • Lithuania · Decitabine Accord, Decitabine Ever Pharma
  • Latvia · Decitabine Ever Pharma
  • Netherlands · Decitabine Ever Pharma, Decitabine Hikma
  • Norway · Dacogen, Decitabin Teva
  • Portugal · Decitabina Accord, Decitabina Eugia
  • Romania · Decitabină Accord, Decitabină Sandoz
  • Sweden · Decitabin Teva, Decitabine Accord
  • Slovenia · Decitabin Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b3310049-9d33-416a-9535-7b608ca7dfa5
GET /v1/drugs/b3310049-9d33-416a-9535-7b608ca7dfa5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01BC",
    "L01BC08"
  ],
  "strength": null,
  "pa_number": "EU/1/12/792/001",
  "substances": [
    "Decitabine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": null,
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about decitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.